Risk-based centralized data monitoring of clinical trials at the time of COVID-19 pandemic

被引:9
|
作者
Afroz, Most Alina [1 ]
Schwarber, Grant [2 ]
Bhuiyan, Mohammad Alfrad Nobel [2 ]
机构
[1] Begum Rokeya Univ, Dept Elect & Elect Engn, Rangpur, Bangladesh
[2] Medpace Inc, Dept Biostat, 5375 Medpace Way, Cincinnati, OH 45227 USA
关键词
Centralize data monitoring; Risk based data monitoring; DATA QUALITY;
D O I
10.1016/j.cct.2021.106368
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: COVID-19 pandemic caused several alarming challenges for clinical trials. On-site source data verification (SDV) in the multicenter clinical trial became difficult due to travel ban and social distancing. For multicenter clinical trials, centralized data monitoring is an efficient and cost-effective method of data monitoring. Centralized data monitoring reduces the risk of COVID-19 infections and provides additional capabilities compared to on-site monitoring. The key steps for on-site monitoring include identifying key risk factors and thresholds for the risk factors, developing a monitoring plan, following up the risk factors, and providing a management plan to mitigate the risk. Methods: For analysis purposes, we simulated data similar to our clinical trial data. We classified the data monitoring process into two groups, such as the Supervised analysis process, to follow each patient remotely by creating a dashboard and an Unsupervised analysis process to identify data discrepancy, data error, or data fraud. We conducted several risk-based statistical analysis techniques to avoid on-site source data verification to reduce time and cost, followed up with each patient remotely to maintain social distancing, and created a centralized data monitoring dashboard to ensure patient safety and maintain the data quality. Conclusion: Data monitoring in clinical trials is a mandatory process. A risk-based centralized data review process is cost-effective and helpful to ignore on-site data monitoring at the time of the pandemic. We summarized how different statistical methods could be implemented and explained in SAS to identify various data error or fabrication issues in multicenter clinical trials.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Reportage A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic
    Tiu, Crescens
    Shinde, Rajiv
    Yap, Christina
    Baikady, Bindumalini Rao
    Banerji, Udai
    Minchom, Anna R.
    de Bono, Johann S.
    Lopez, Juanita S.
    LANCET ONCOLOGY, 2020, 21 (07): : 889 - 891
  • [2] Remote Monitoring in Clinical Trials During the COVID-19 Pandemic
    Izmailova, Elena S.
    Ellis, Robert
    Benko, Christopher
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 838 - 841
  • [3] Clinical trials and the COVID-19 pandemic
    Retsas, Spyros
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (01): : 4 - 5
  • [4] Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials
    Joffe, Steven
    Babiker, Abdel
    Ellenberg, Susan S.
    Fix, Alan
    Griffin, Marie R.
    Hunsberger, Sally
    Kalil, Jorge
    Levine, Myron M.
    Makgoba, Malegapuru W.
    Moore, Renee H.
    Tsiatis, Anastasios A.
    Whitley, Richard
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (12): : 1995 - 2000
  • [5] Remote digital monitoring in clinical trials in the time of COVID-19
    Jennifer C. Goldsack
    Elena S. Izmailova
    Joseph P. Menetski
    Steven C. Hoffmann
    Peter M.A. Groenen
    John A. Wagner
    Nature Reviews Drug Discovery, 2020, 19 : 378 - 379
  • [6] Remote digital monitoring in clinical trials in the time of COVID-19
    Goldsack, Jennifer C.
    Izmailova, Elena S.
    Menetski, Joseph P.
    Hoffmann, Steven C.
    Groenen, Peter M. A.
    Wagner, John A.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (06) : 378 - 379
  • [7] Clinical trials, adaptability and the COVID-19 pandemic
    Eskander, Ramez N.
    Pothuri, Bhavana
    Randall, Leslie
    O'Malley, David
    Slomovitz, Brian
    Moore, Kathleen
    Coleman, Robert
    Herzog, Thomas
    Monk, Bradley J.
    Copeland, Larry
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 35
  • [8] Clinical trials during COVID-19 pandemic
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E88 - E89
  • [9] Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis
    Weichung J. Shih
    Chen Yao
    Tai Xie
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 1236 - 1255
  • [10] Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic Crisis
    Shih, Weichung J.
    Yao, Chen
    Xie, Tai
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1236 - 1255